Open Access

AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease

  • Authors:
    • Tian‑Jing Liu
    • Yong‑Yan Shi
    • En‑Bo Wang
    • Tong Zhu
    • Qun Zhao
  • View Affiliations

  • Published online on: December 14, 2015     https://doi.org/10.3892/mmr.2015.4686
  • Pages: 1156-1162
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Angiotensin Ⅱ, which is the main effector of the renin‑angiotensin system, has an important role in intestinal inflammation via the angiotensin Ⅱ type 1 receptor (AT1R). The present study aimed to investigate the protective effects of the AT1R blocker losartan on 2,4,6‑trinitrobenzenesulphonic acid (TNBS)‑induced colitis. Losartan was administered to male adult C57BL/6 J mice 2 weeks prior to the induction of colitis, and images of the whole colon were captured to record changes, scored according to a microscopic scoring system, and reverse transcription‑quantitative polymerase chain reaction were performed in order to investigate colonic inflammation. In addition, intestinal epithelial barrier permeability was evaluated, and intestinal epithelial cell (IEC) apoptosis was measured using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and apoptosis‑related protein expression levels were detected by western blotting. Losartan was able to attenuate TNBS‑induced body weight loss and colonic damage. Furthermore, T helper 1‑mediated proinflammatory cytokines were suppressed by losartan, and gut permeability was largely preserved. TUNEL staining revealed reduced IEC apoptosis in the losartan‑treated mice. Losartan also increased the B‑cell lymphoma 2 (Bcl‑2)/Bcl‑2‑associated X protein (Bax) ratio and suppressed caspase‑3 induction. These results suggested that the AT1R blocker losartan may attenuate TNBS‑induced colitis by inhibiting the apoptosis of IECs. The effects of losartan were partially mediated through increasing the Bcl‑2/Bax ratio and subsequently suppressing the induction of the proapoptotic mediator caspase‑3.
View Figures
View References

Related Articles

Journal Cover

February-2016
Volume 13 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu TJ, Shi YY, Wang EB, Zhu T and Zhao Q: AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease. Mol Med Rep 13: 1156-1162, 2016
APA
Liu, T., Shi, Y., Wang, E., Zhu, T., & Zhao, Q. (2016). AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease. Molecular Medicine Reports, 13, 1156-1162. https://doi.org/10.3892/mmr.2015.4686
MLA
Liu, T., Shi, Y., Wang, E., Zhu, T., Zhao, Q."AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease". Molecular Medicine Reports 13.2 (2016): 1156-1162.
Chicago
Liu, T., Shi, Y., Wang, E., Zhu, T., Zhao, Q."AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease". Molecular Medicine Reports 13, no. 2 (2016): 1156-1162. https://doi.org/10.3892/mmr.2015.4686